Table 2

Emergence of Bluetongue Virus Serotype 3, the Netherlands, September 2023

Melle Holwerda¹

, Inge M.G.A. Santman-Berends¹, Frank Harders, Marc Engelsma, Rianka P.M. Vloet, Eveline Dijkstra, Rene G.P. van Gennip, Maria H. Mars, Marcel Spierenburg, Lotte Roos, René van den Brom¹, and Piet A. van Rijn¹

Author affiliations: Wageningen Bioveterinary Research, Lelystad, the Netherlands (M. Holwerda, F. Harders, M. Engelsma, R.P.M. Vloet, R.G.P. van Gennip, P.A. van Rijn); Royal GD, Deventer, the Netherlands (I.M.G.A. Santman-Berends, E. Dijkstra, M.H. Mars, L. Roos, R. van den Brom); Netherlands Food and Consumer Product Safety Authority, Utrecht, the Netherlands (M. Spierenburg); North-West University, Potchefstroom, South Africa (P.A. van Rijn)

Main Article

Percentage homology between BTV-3/NET2023 variant and closest isolates deposited in GenBank in study of emergence of BTV-3 in the Netherlands, September 2023*

Segment	Virus protein	Highest % identity†	Isolate name	GenBank accession no.
Seg-1	VP1	97.69	BTV-8/2020_13	OQ860824.1
Seg-2	VP2	98.09	BTV-3/ZIM2002/01	AJ585179.1
Seg-3	VP3	98.30	BTV-5/O.aries-tc/ZAF/2011/Benoni_01012015	MG255451.1
Seg-4	VP4	98.37	BTV-3/TUN2016/Zarzis	MF124295.1
Seg-5	NS1	98.42	BTV-1/ISR-2050/19	OM502356.1
Seg-6	VP5	97.50	BTV-3/O.aries-tc/ZAF/2017/Smithfield_VR33	MG255623.1
Seg-7	VP7	98.27	BTV-3/O.aries-tc/ZAF/2016/Waterval_Boven_VR22	MT028405.1
Seg-8	NS2	97.69	BTV-2/O.aries-tc/ZAF/2017/Queenstown_VR18	MG255577.1
Seg-9	VP6/NS4	97.43	BTV-4/SPA2003/03	KP821911.1
Seg-10	NS3/NS3a	98.42	BTV-18/BT32/76	JX272448.1

*BTV-3/NET2023 variant was isolated from sheep in the Netherlands in September 2023 and genome segments were compared with those of BTV isolates deposited in GenBank. BTV-3, bluetongue virus serotype 3; NS, nonstructural protein; Seg, genome segment; VP, virus protein. †Highest % identity (>97%) compared with BTV-3/NET2023.

Main Article

¹These authors contributed equally to this article.

Page created: June 13, 2024

Page updated: July 20, 2024

Page reviewed: July 20, 2024

The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.